Back to search

Article

Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase producing Enterobacterales

2023-11-16

Abstract excerpt

Infections with Enterobacterales (E) are increasingly difficult to treat due to antimicrobial resistance. After ceftriaxone replaced chloramphenicol (CHL) as empiric therapy for suspected sepsis in Malawi in 2004, ESBL-E rapidly emerged. Concurrently, resistance to CHL in Escherichia coli and Klebsiella spp. decreased, raising the possibility of CHL re-introduction. However, many phenotypically susceptible isola...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
00957dd9-79e0-5914-b384-de34c5daf177
DOI
10.1101/2023.11.16.567242
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 9 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Molecular mechanisms of re-emerging chloramphenicol susceptibility in extended-spectrum beta-lactamase producing EnterobacteralesDOI 10.1101/2023.11.16.567242
Select a neighboring publication to make it the new centre.